Application 021204
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | STARLIX | NATEGLINIDE | TABLET;ORAL | 60MG | Yes | No |
| 002 | STARLIX | NATEGLINIDE | TABLET;ORAL | 120MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021204-001 | STARLIX | NATEGLINIDE | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | |
| N021204-002 | STARLIX | NATEGLINIDE | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021204-001 | STARLIX | 60MG | TABLET / ORAL | RLD | 2000-12-22 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021204-002 | STARLIX | 120MG | TABLET / ORAL | RLD | 2000-12-22 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2000-12-22 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2000-12-22 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021204-001 | STARLIX | 60MG | TABLET / ORAL | RLD | 2000-12-22 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021204-002 | STARLIX | 120MG | TABLET / ORAL | RLD | 2000-12-22 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021204-001 | STARLIX | 60MG | TABLET / ORAL | RLD | 2000-12-22 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021204-002 | STARLIX | 120MG | TABLET / ORAL | RLD | 2000-12-22 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021204-001 | STARLIX | 60MG | TABLET / ORAL | RLD | 2000-12-22 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021204-002 | STARLIX | 120MG | TABLET / ORAL | RLD | 2000-12-22 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021204-001 | STARLIX | 60MG | TABLET / ORAL | RLD | 2000-12-22 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021204-002 | STARLIX | 120MG | TABLET / ORAL | RLD | 2000-12-22 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021204-001 | STARLIX | 60MG | TABLET / ORAL | RLD | 2000-12-22 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021204-002 | STARLIX | 120MG | TABLET / ORAL | RLD | 2000-12-22 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021204-001 | STARLIX | 60MG | TABLET / ORAL | RLD | 2000-12-22 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021204-002 | STARLIX | 120MG | TABLET / ORAL | RLD | 2000-12-22 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021204-001 | STARLIX | 60MG | TABLET / ORAL | AB | RLD | 2000-12-22 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021204-002 | STARLIX | 120MG | TABLET / ORAL | AB | RLD, RS | 2000-12-22 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021204-001 | STARLIX | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021204-002 | STARLIX | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2000-12-22 | 3a93d1ddd44b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | N021204-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021204-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nateglinide | NATEGLINIDE | Golden State Medical Supply, Inc. | e920b343-f53e-7487-e053-2995a90a719a | 2025-04-15 | Warnings, Adverse reactions | NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Strides Pharma Science Limited | 0ccf9b07-3c21-482d-abeb-a06ceb482c7b | 2025-02-24 | Warnings, Adverse reactions | NATEGLINIDE |
| Nateglinide | NATEGLINIDE | American Health Packaging | b17ead66-dc11-4e54-9ba6-00619510f27b | 2025-01-07 | Warnings, Adverse reactions | NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Zydus Lifesciences Limited | a82817dd-f8c4-4172-ba86-63c2beef456a | 2024-12-03 | NATEGLINIDE | |
| NATEGLINIDE | NATEGLINIDE | Rising Pharma Holdings, Inc. | b41f4180-96a7-411d-b827-5021e534f556 | 2024-12-03 | Warnings, Adverse reactions | NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Zydus Pharmaceuticals USA Inc. | 88698921-cd8f-4d41-96e6-ff671913c5c3 | 2023-11-07 | Warnings, Adverse reactions | NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Cadila Pharmaceuticals Limited | c678b772-acba-4b59-a0b2-d70d84283425 | 2022-12-28 | Warnings, Adverse reactions | NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Dr. Reddy's Laboratories Limited | f7b28951-76d2-cabd-64a1-b74aa225c6e9 | 2021-11-27 | Warnings, Adverse reactions | NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Modavar Pharmaceuticals LLC | af81465b-5f49-4eeb-8122-ef7fe5d90ddc | 2021-08-03 | Warnings, Adverse reactions | NATEGLINIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0078-0351 | Starlix | nateglinide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0351 | Starlix | nateglinide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0351 | Starlix | nateglinide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0351 | Starlix | nateglinide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0352 | Starlix | nateglinide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0352 | Starlix | nateglinide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0352 | Starlix | nateglinide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0352 | Starlix | nateglinide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0352 | Starlix | nateglinide | Novartis Pharmaceuticals Corporation | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 69166 | SUPPL | 2021-10-29 |
| 69153 | SUPPL | 2021-10-29 |
| 54246 | SUPPL | 2018-05-18 |
| 54191 | SUPPL | 2018-05-15 |
| 48133 | SUPPL | 2017-04-27 |
| 47608 | SUPPL | 2017-03-20 |
| 36342 | SUPPL | 2011-08-26 |
| 27057 | SUPPL | 2011-08-26 |
| 4631 | SUPPL | 2008-07-17 |
| 36341 | SUPPL | 2008-07-16 |
| 42020 | SUPPL | 2007-07-06 |
| 27056 | SUPPL | 2006-11-14 |
| 36340 | SUPPL | 2006-11-13 |
| 14631 | SUPPL | 2004-07-07 |
| 27055 | SUPPL | 2004-07-06 |
| 27054 | SUPPL | 2003-10-27 |
| 14630 | SUPPL | 2003-10-27 |
| 36339 | SUPPL | 2002-11-26 |
| 4630 | SUPPL | 2002-11-26 |
| 21505 | ORIG | 2002-03-18 |
| 36338 | ORIG | 2000-12-22 |
| 4629 | ORIG | 2000-12-22 |